Andrew Limbek - 20 May 2022 Form 4 Insider Report for PSYCHEMEDICS CORP (PMDI)

Reporting relationship: Vice President & Controller
Issuer ticker: PMDI
Reported as of: 20 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 May 2022, 17:39:11 UTC
Prior SEC filing: 17 May 2022
Source filing: View source filing
Reporting owner signature: Patrick J. Kinney, Jr., as attorney-in-fact for Andrew Limbek

Key filing fact

Andrew Limbek filed Form 4 for PSYCHEMEDICS CORP (PMDI) on 24 May 2022.

Key facts

This page summarizes Andrew Limbek's Form 4 filing for PSYCHEMEDICS CORP (PMDI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 May 2022, 17:39.

Change

Previous filing in this sequence was filed on 17 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMD transaction

Common Stock, $.005 Par Value

Award

Transaction value: $0
Shares: +7,000
Change %: +102%
Price: $0.000000
Shares after: 13,863
Date: 20 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversay date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date,